XML 70 R58.htm IDEA: XBRL DOCUMENT v3.22.4
Restructuring, Impairment and Other Costs of Terminated Program - Summary of Restructuring Costs (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Restructuring and Related Activities [Abstract]      
Clinical trial expense, other third-party and employee costs for the wind down of the bempegaldesleukin program $ 31,693    
Severance and benefit expense 30,904    
Impairment of right-of-use assets and property, plant and equipment 65,761 $ 0 $ 0
(Gain) loss on sale or disposal of property, plant and equipment, net (3,326) $ 0 $ 0
Contract termination and other restructuring costs 10,898    
Restructuring, impairment and other costs of terminated program $ 135,930